The Role of Nonmuscle Myosin IIA in Endothelial Cell
Introduction
The vascular system is lined by a continuous sheet of endothelial cells. The individual endothelial cell is typically a flattened, extended polygonal cell which interfaces with its multiple neighbors through a modest variety of junctional specializations characteristic of its site in the circulation. In vivo, the flattened state of cell abutted to cell is the usual condition. However, under the influence of a variety of stimuli, sizable gaps form between endothelial cells allowing the passage of large molecules otherwise confined to the circulation [1] [2] [3] [4] . Evidence that the opening of endothelial cell junctions depending on an active contractile process was first presented by Majno and Palade [5] . These investigators observed in stimulated post-capillary venules that the endothelial cells bulged into the lumen and their nuclei developed numerous superficial pleats. Majno also observed that the endothelial cells expressed a prominent array of fine cytoplasmic filaments, which he proposed could generate the required contractile force [1, 5] . This evidence provided a basis for the theory of endothelial cell contractility, while it need further support. In the early 80's several laboratories demonstrated gap formation between cultured endothelial cells upon exposure to thrombin [6] [7] [8] . Rotrosen et al. [9] extended the observation to histamine while Shasby et al. [10] described a more severe retraction when endothelial cells were exposed to cytochalasin B. Furthermore, cytokines also induce gap formation that appears indistinguishable from histamine and thrombin.
Our laboratory has reported on the formation of gaps between endothelial cells induced by ethchlorvynol, an agent capable of increasing pulmonary capillary permeability and causing pulmonary edema [2, 11] . We extended our studies to show similar
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effects with histamine, thrombin and PAF [12] [13] [14] . In our studies, the shape change is reversible and there is no injury to the cells. We have also shown that the change in Factin associated with shape change of the endothelial cell occurs in an ATP-dependent manner [15] . Our laboratory used the term retraction initially to avoid any a prior implication that it requires actomyosin-mediated contractile event. However, we now know from our permeabilized cell studies [12, 15] and from intact preparations [13, 14, 16] that endothelial cells possess a myosin light chain kinase (MLCK) controlled contractile mechanism. Our laboratory has published a method that allows quantitative measurements of contractile force generated by cells grown within a collagen gel or by cells grown on top of a collagen matrix [14] . We have utilized the phosphorylation hypothesis as a prototype to study the mechanism of endothelial cell contractility [12, 17] .
Endothelial cells do not appear to contract in the sense of shortening along a single axis as smooth muscle cells do. Instead, peripheral regions of the polygonal cell focally withdraw leaving spaces between adjacent cells which typically remain connected by tenuous processes [11, 12, 15, 17] . Clues to the mechanism of contraction of endothelial cells have been provided by such diverse cell types as smooth muscle cells [18] [19] [20] [21] fibroblasts [13, [22] [23] [24] RBL cells [25, 26] and leukocytes [27] . Smooth muscle cells, unlike endothelial cells, contract in a polarized fashion.
The common event causing the stimulation of smooth muscle contraction is the increase in cytosolic free Ca 2+ . According to the simplest proposed model, Ca 2+ associates with calmodulin and this complex activates MLCK which in turn results in phosphorylation of myosin light chain (MLC) thus initiating contraction [21, 28] . The phosphorylation of the 20 kD MLC results in activation of the actin activated Mg-ATPase activity of myosin which allows myosin to hydrolyze ATP and affect the transformation of chemical energy to mechanical work. Our permeabilized monolayer studies strongly implicated MLCK and MLC phosphorylation as the mechanism responsible for initiation of endothelial cell retraction. Our laboratory as well as Garcia's utilizing thrombin [29] and studies from Shasby's laboratory [30] with histamine have confirmed that stimulation with inflammatory agonists induces MLC phosphorylation.
Myosin light chain kinases are serine/threonine kinases that specifically catalyze the phosphorylation of serine-19 (Ser19) and threonine-18 (Thr18) in the 20 kD regulatory light chain of myosin II [31] [32] [33] . Phosphorylation of myosin light chain by MLCK is responsible for initiation of contraction in smooth muscle and leads to potentiation of contraction in skeletal muscle [34, 35] . However, the function of MLCK and myosin II in the control of nonmuscle contractility is not well understood. In vitro studies have suggested that MLCK may control the activity of nonmuscle myosin in nonmuscle cells.
Phosphorylation of Ser19 by MLCK regulates both filament formation [14, 32, 36] and the myosin II actin activated ATPase activity [18, 33] while diphosphorylation of MLC at both Ser19/Thr18 by MLCK has been implicated in increased filament stability and has been shown to further increase myosin II ATPase activity in vitro [37] .
So far, investigated vertebrates appear to contain three different isoforms of the conventional nonmuscle myosin II, designated as nonmuscle myosin IIA, myosin IIB and myosin IIC [38, 39] . Although the precise functions of these myosins are not well understood, the mRNA encoding each isoform appears to be consistently expressed across many tissue and cell lines [40] [41] [42] . Since these isoforms are regulated by phosphorylation of the 20kD light chains, it is plausible that differential targeting of isoform phosphorylation dictates unique cellular distributions and/or functions. It has been well known that myosin IIA is involved in the generation of contraction in nonmuscle cells and this process requires the actin cytoskeleton, specifically the localized polymerization of actin filaments. Myosin IIA is a potent motor protein responsible for cell contraction, but the specific molecular mechanisms are poorly understood.
Recent study indicates that endothelial barrier integrity depends on the actin and myosin cytoskeleton [43, 44] . One possible mechanism of increase of vascular permeability is endothelial cell contraction. However, it is not completely understood how myoactin cytoskeleton is involved in endothelial cell contraction and results in an alteration in cell permeability. Understanding the molecular mechanisms of myosin IIA function in endothelial cells will identify novel therapeutic targets for human diseases that arise due to defects in endothelial barrier integrity.
In this study, the subject is to explore the role of nonmuscle myosin IIA in endothelial cell by knocking down nonmuscle myosin IIA expression in mouse vascular endothelial cells.
Materials And Methods

Cell Culture and Reagents
Mouse endothelial cell line obtained from mouse lung tissue was a generous gift of Dr.
Troy Stevens, University of South Alabama.
Cells were cultured in minimal essential media (MEM) supplemented with 10%
heat-inactivated fetal bovine serum, 50 unit/ml penicillin and 50 µg/ml streptomycin at 37 • C under the humidified atmosphere of 5% CO 2 and 95% air. Cells were split at a ratio of 1:4 every 7-8 days.
Immunofluorescence Microscopy
Control and infected endothelial cells were washed with pre-warmed PBS 3 times, fixed with freshly made 37 • C fixative (1% formaldehyde in stabilization buffer, pH 6.5) for 1 minute at 37 • C, followed by incubation with fixation and permeabilization buffer (2% formaldehyde, 0.2% triton X-100, 0.5% DOC in stabilization buffer, pH 6. Pictures were taken on a Zess 510 confocal microscope and Z series images were built into composite micrographs.
For staining of myosin IIA + actin or myosin IIB + actin, myosin IIA or myosin IIB were stained in 0.25 µg/ml affinity purified rabbit polyclonal anti-myosin IIA or anti-myosin IIB primary antibody and followed by Alexa 488 labeled goat anti rabbit secondary antibody. Actin filaments were stained with 1.0 µg/ml rhodamine phalloidin (Sigma, Cat No. P1591) for 1 hour at room temperature. For double staining of myosin IIA + myosin IIB, myosin IIA was stained with 1.0 µg/ml working concentration of rabbit polyclonal anti-myosin IIA, followed by Alexa 488 labeled donkey anti rabbit secondary antibody. Myosin IIB was stained with 1.5 µg/ml working concentration of affinity purified goat polyclonal primary antibody, followed by Alexa 568 labeled donkey anti goat secondary antibody.
Virus Amplification
Adenovirus encoding short hairpin interfering RNA targeting a mouse nonmuscle myosin IIA (shRNAi-IIA) was amplified in 293T cells. Cells were seeded into T75 cm 2 flask 24 hour prior to infection. After achieving 70-80% confluence, 293T cells were washed 3 times with serum free MEM media without penicillin/streptomycin, incubated with media containing virus at 37 • C for 2 hours. After infection, cell cultures were fed with media (without penicillin/streptomycin) with 10% fetal bovine serum and incubated at 37 • C. After most of the cells become round (about 24 hours post infection), cells were dislodged by pipeting up and down, media and cells were collected and spun down at 1000×g (2000 rmp), 4 • C for 20 minutes. Cell pellets were re-suspended in 5 ml of sterile 100 mM Tris buffer (pH8). Cell pellets were frozen in a dry-ice-methanol slurry and immediately thawed in a 37 • C water bath. Cell pellets were processed through 3 freeze-thaw cycles. Cell lysates were spun down at 1000×g (2000 rpm) at 4 • C for 20 minutes, supernatant was saved and pellet was discarded.
CsCl Purification
CsCl gradients were prepared in SW-40T tubes (Beckman ultra clear tubes, Cat344059): The tube was punctured below the band for withdrawing only the viral particles.
A second CsCl gradient in polyallomar quick seal tubes was prepared (Beckman 13x51mm, Cat342412).
Tubes were placed on ice and virus was added to the bottom of each tube, then 1.34 g/cc (13.5 g of CsCl in 30 ml of 100 mM Tris buffer pH 8, 10 mM EDTA) was added to the top of the dome.
Sealed tubes were spun at 320000×g (60,000 rmp) at 4 • C overnight (more than 8 hours) in the rotor VTi65.2.
PD10 columns (PD10 sephadex G25, pre-packed column) were washed twice with 25 ml of sterile 30% glycerol in PBS. After removing tubes from centrifuge, the top of each tube was punctured to release pressure. A white and fluffy band containing virus was collected with an 18G gauge needle attached to a 5 ml sterile syringe.
Virus was placed on PD-10 column. 10 ml of 30% glycerol/PBS solution was added to the column, and 500 µl fractions were collected. All samples were analyzed by using Nanodrop spectrophotometers at OD 260 nm to determine which fraction contain purified virus. Virus was stored at -80 • C. Cells were sonicated and heated at 100 • C for 10 minutes to denature proteins and samples were stored frozen at -80 • C.
Adenovirus Infection
SDS samples were run on 10% SDS-PAGE gels and then transferred to PVDF membrane. 0.1% SDS was included in transfer buffer to help facilitate protein transfer.
Membranes were incubated with the affinity purified primary antibodies against NMHC IIA (rabbit polyclonal anti-myosin IIA, 0.025 µg/ml), NMHCIIB (rabbit polyclonal anti-myosin IIB, 0.025 µg/ml), and GAPDH (Sigma, Cat. No. G8795, mouse monoclonal, 1:10,000 dilution) at room temperature for 3 hours, followed by incubation with horseradish peroxidase-conjugated secondary antibodies at 1:5000 dilution (goat anti rabbit) at room temperature for 1 hour. The immunoblotted proteins were incubated with ECL reagent and exposed to X-ray film. After baseline force was developed, cell rings were stimulated with 2 unit/ml thrombin.
Isometric Tension Measurements
After achieving stable tension, the cell rings were treated with 2 µM cytochalasin D.
Attachment and Spreading Measured by ECIS
Control or infected cells were seeded onto ECIS cultureware (100,000 per well, 0.8 cm 2
per well) pre-coated with collagen (5 µg/well). The ECIS measurement was started immediately after cells were seeded into chambers. Cells attached and spread on the small gold electrode on the bottom of the chamber. A current passed between the small gold-film electrode and a larger gold counterelectrode. As cultured cells attach and spread onto the electrodes, the current has to flow in the spaces under and between the cells which causes the increase in the electrical resistance, as the cell membrane is essentially an insulator. The total time duration of measurement is 24 hours.
Cell Motility
Control or infected cells were seeded onto 35 mm dish (50,000 per dish) and subjected to cell motility measurement by Nikon Swep Field confocal system 24 hours after cast- 
Results
Adenovirus Infection
In order to determine the optimal condition for reducing the level of myosin IIA in mouse endothelial cells, experiments were undertaken to assess the appropriate incubation dose and time needed to reduce nonmuscle myosin IIA using adenovirus encoding an shRNAi to nonmuscle myosin IIA in cells. Blots were probed with affinity purified antibody to myosin IIA. As shown in figure 1,
the shRNAi-IIA probe is effective in reducing endogenous endothelial cell myosin IIA. After 48 hours incubation with virus, the myosin IIA level was reduced by 48%.
Further increasing the incubation time to 72 hours and 96 hours, we achieved a reduction in myosin IIA of 71% and 81% respectively (figure 3.2). Maximal reduction of myosin IIA occurred after 96 hours incubation with ad-shRNAi-IIA. After 96 hours, a 90% reduction in myosin IIA content occurred in respond to a dose of MOI 100 per cell as shown in figure 3 .3 A.
Since myosin IIA and myosin IIB heavy chains have similar structural characteristics, cell lysates were probed with affinity purified myosin IIB antibody to ensure that our IIA probe had no effect on myosin IIB content. As shown in figure 3. 3 B, incubation of cells with adnovirus encoding shRNAi-IIA had no effect on myosin IIB content while reducing myosin IIA levels by 90% ( figure 3.3 B ).
Myosin II and Actin Localization in Preconfluent Endothelial Cells
It's well-known that nonmuscle myosin II and F-actin have a fundamental role in regulating cell shape, motility and force development. In tissue culture dishes preconfluent endothelial cells assume various shapes with different cytoskeletal organization. As cells grow, divide and contact one another, their cytoskeleton continuously changes until reaching a stable configuration 5-6 day after being seeded onto culture dishes.
At confluence endothelial cells form a sheet of polygonal cells tightly attached to one
another forming a semi-permeable membrane that regulates the movement of solutes across the monolayer. Since, endothelial cells change shapes as they grow, we sought to determine the structural differences in myosin II and actin organization in endothe-lial cells 24 hours after seeding from endothelial cells within a confluent monolayer 5 day post seeding. Figure 3 .4 illustrates the distribution of myosin IIA and actin and figure 3.5 myosin IIB and actin within representative cell morphologies identified in culture. Actin filaments for the most part were bundled into stress fibers that ran parallel to the long axis of the cell. In one group of cells ( Fig. 3 .4A and 3.5A) there was a complex array of paranuclear actin filaments with small filaments emanating radialy for this complex. In a second group (Fig. 3.4B and 3 .5B) the actin filamants varied in length, ran parallel to one another but had no paranuclear actin complex. In the last group identified Fig. 3 .4C and 3.5C actin filaments appeared to arise from a paranuclear array of filaments and coursed toward the periphery of the cell in a radial spoke like pattern. Both myosin IIA ( Fig. 3.4 ) and IIB ( Fig. 3 .5) were associated with the underlying actin filaments however myosin IIA was more concentrated within the paranuclear actin arrays.
To determine if myosin IIA has a role in forming and maintaining these structures, experiments were undertaken to knock down myosin IIA in endothelial cells and determine what effects loss of myosin IIA had on the cellular cyto-architecture. Endothelial cells were infected with a adenovirus encoding a shRNAi to myosin IIA, cells were harvested 96 hours post infection and seeded at preconflunet densities fixed 24 hrs after seeding and stained for either myosin IIA/actin ( Fig. 3.6 ) or myosin IIB/actin ( Fig.   3 .8) staining. Parallel dishes were harvested for SDS gels analysis to determine the extent of myosin IIA knock down ( Fig. 3 .7A) and to show shRNA-IIA constructs did not alter myosin IIB protein levels ( Fig. 3.7B ). Treatment of cultures with our adenovirus encoding shRNAi-IIA at MOI 100 per cell resulted in 90% reduction of myosin IIA with no significant affect on myosin IIB levels ( Fig. 3.7B ). Immunofluoresent localization studies showed major reductions in myosin IIA levels within all cells compared to controls ( Fig. 3.4) . However, the total amount of IIA loss varied somewhat from cell to cell. Two levels of NMHC-IIA knock down cells were identified. Fig. 3 .6A illustrates a representative cell where negligible amounts of myosin IIA remain within the cytoplasm. The lingering myosin IIA is randomly dispersed throughout the cytoplasm taking on no distinct pattern. Cells with this phenotype were larger in size and display large protruding lamella from different regions of their cell body. Co-staining these cells with rhodamine phalloidin showed loss of NMHC-IIA has a striking effect on underlying actin stress fibers. The ordered stress fiber organization within the cytoplasm was lost. Stress fiber that remain were short filaments randomly orientated concentrated near the nuclear region while membrane protrusions were filled with a fine reticular meshwork of actin filaments (Fig. 3.6A ). The majority (>85%) of infected cells exhibited this phenotype. About 15% of the cells observed still had detectable myosin IIA present within the cytoplasm. Myosin IIA localized at the cell periphery and associated with underlying actin filaments. Actin filament structure was disorganized, however, the number of actin filaments present in cells and the degree of disruption did not directly correlate with the extent of myosin IIA knock down. The content of myosin IIB minimally changed in NMHC-IIA knock down cells ( Fig. 3.7B ). Myosin IIB co-localized with the actin stress fibers and the fine actin meshwork that formed in myosin IIA knock down cells ( Fig. 3.8A-C) . These results confirmed the specificity of Ad-shRNAi knock down construct and showed that myosin IIB association with actin appeared unaltered in NMHC-IIA knock down cells.
In order to directly compare the localization of myosin IIA and myosin IIB in control and NMHC-IIA knockdown endothelial cells, cultures were fixed and double stained for myosin IIA and myosin IIB. As shown in figure 3.9 myosin IIA and myosin IIB exhibited a sarcomeric like distribution associated with the underlying actin filaments. This was the same distribution found in untreated control cells stained for myosin IIA/actin and 
Myosin II and Actin Localization in Confluent Monolayers
IIB/actin alone (Fig. 3.4 and 3.6 ). NMHC-IIA knock down resulted in disruption but not complete loss of actin stress fibers. Myosin IIB associated with stress fibers as well as the fine actin network that formed within the cell cytoplasm. Staining for myosin IIA/IIB/actin in control and myosin IIA knockdown cultures confirmed our previous results. Besides a slight change in cell shape, monolayers appeared unaffected as examined by light microscopy. In contrast, monolayers infected with ad-shRNAi-IIA and stained for myosin IIA/actin showed loss of myosin IIA from the cell margins while small aggregates of myosin IIA staining material formed within the cytoplasm. The actin localization at the cell periphery was also lost while the cytoplasmic stress fibers appeared shorter and more disorganized. In control, monolayers myosin IIB localized to the boarders between cells similar to that seen with myosin IIA (Fig. 3.11 ). Small droplets of myosin IIB were also distributed throughout the cytoplasm. F-actin localized to the cell margins and central stress fibers and myosin IIB was found decorating their structures. In myosin IIA knocked down cells, myosin IIB appeared minimally altered. Myosin IIB remained localized at cell margins. However, myosin IIB appeared to associate more prominently with central stress fibers. 
Cell Attachment and Spreading
Knocking down of myosin IIA alter both the actin and myosin II cytoskeleton in both pre-confluent and post confluent endothelial cells. Since, the cytoskeleton is critical for cell attachment and spreading and we wanted to determine if reorganization of the cytoskeleton altered the rate and degree of endothelial cell attachment and spreading.
For these experiments we used Electric Cell-substrate Impedance Sensing (ECIS) measurements to follow changes in cell attachment and spreading in control and infected endothelial cells.
Collagen coated ECIS culture chambers were placed in the ECIS apparatus. Control and ad-shRNA-IIA infected mouse endothelial cells were seeded into chambers and measurements started immediately. 
Myosin IIA and Endothelial Cell Motility
Our result showed myosin IIA was involved in modulating cell adhesion and spreading, which were early events in cell migration. To determine the role of myosin IIA in endothelial cell migration, experiments were undertaken to directly measure the rate of endothelial cell movement in control and myosin IIA knockdown endothelial cells. 50,000 control or myosin IIA knockdown cells were seeded onto dishes and allowed to adhere and spread for 12 hours before motility measurements were performed. Cultures were washed with media containing 0.25% BSA 30 minutes prior to the start of an experiment to remove virus. Parallel cultures were maintained under identical conditions to assess the effects of the adenovirus constructs on the levels of myosin IIA.
Western blot analysis showed that cells treated with adenovirus encoding shRNAi-IIA showed a 80% reduction of myosin IIA levels ( Fig. 3.15 ). Fig. 3 .13 while the migratory path of myosin IIA knockdown cells is shown in Fig. 3 .14. The rate of cell movement (µm/hr) is shown in Table 3 .1. Myosin IIA knockdown cells ( Fig. 3.14) were more spread and bigger than control cells ( Fig. 3.13 To further analyze the cell motility, Fig. 3 .16 illustrated the positions of cells at 30 minute interval for the duration of experiment. One axis is angular data (degree), another axis is radial data (µm). The control endothelial cells tended to stay near the point of origin which indicated that most control cells barely moved during the 
Effects of Myosin IIA on Isometric Tension
Since, actin and myosin are responsible for generating endothelial cell contractile forces [48] , we sought to determine if loss of myosin IIA alters the contractile force produced by endothelial cells. In this last set of experiments, we directly measured the contractile force produced by endothelial cell depleted of myosin IIA. Isometric tension measurements were performed as outlined by Goeckeler and Wysolmerski [14] . Representative force tracings are shown in Fig. 3.17 . Depletion of myosin IIA (green tracing) resulted in about 41% reduction in baseline tension compared to control (red tracing). Both myosin IIA knockdown and control monolayers rapidly increased their isometric tension upon stimulation with thrombin. However, myosin IIA depleted monolayers produced about 33% less force than control. Taken together, these results indicate that myosin IIA is essential for endothelial cells to generate basal tension and agonist-stimulated isometric tension. After the baseline force was reached, the cells were stimulated with 2 unit/ml thrombin, which induced a rapid increase in tension. After achieving peak tension, tension dropped to establish a new baseline force. Application of cytochalasin D (Cyto D) depolymerized actin filaments and abolished force production. Western blot result indicated the myosin levels in cells.
Discussion
This study analyzed the role of nonmuscle myosin IIA in regulating endothelial cell shape, motility and contraction by knocking down nonmuscle myosin IIA in endothelial cells with ad-shRNAi-IIA. The western blot result presented that about 90% percent of nonmuscle myosin IIA expression was decreased after MOI 100 per cell infection for 96 hours and it also showed that that nonmuscle myosin IIA expression could be effectively depleted without affecting the levels of the nonmuscle myosin IIB isoform.
Jeon et al. [49] provide evidence that nonmuscle myosin II is responsible for establishing cell polarity and retaining the cellular structure. The regulatory site of nonmuscle myosin regulatory light chain (MRLC) is directly phosphorylated by AMPkinase, which is an enzyme activated in response to energy deprivation. These investigators observed that the defect of AMP-kinase can lead to failure of activation of nonmuscle myosin II and dramatic abnormalities in cellular structure. However, after activation of AMP-kinase, they observed actin cytoskeleton polarization and dramatic changes in cell shape. Our morphology analyses were consistent with their observations that knocking down nonmuscle myosin IIA dramatically changed the cell shape and myoactin cytoskeleton. Our results provide further evidence that knocking down nonmuscle myosin IIA in endothelial cells causes decrease in number of F-actin bundles and increase of fine actin meshwork, which is also consistent with the observations of Sandquist et al [50] .
Cell motility was analyzed in several experiments here, involving initial attachment and spreading measured by ECIS and random migration after attachment, measured by live cell imaging by Nikon swept field confocal system. In the ECIS result, myosin IIA knockdown cell presented a higher resistance during initial attachment, which indicated a faster attachment in myosin IIA knockeddown cells than control cells. This result is consistent with earlier conclusions Jay et al. [51] presented that myosin II contributes to cellular detachment and retraction, and Wylie and Chantler [52] deduced that nonmuscle myosin IIA drive neurite retraction in neuronal cells. Consistent with these conclusons, in the following random migration experiment by using Nikon swept field live cell confocal system, cells were observed more spread and larger in myosin IIA knockeddown cells and the moving rate of random migration was slightly higher than control cells.
Normally, contraction force helps detach the cell tail from the substratum. Since previous result demonstrated that the cellular detachment and retraction were inhibited in myosin IIA knockdown cells, we predicted that the contraction force will be decreased in myosin IIA knockeddown cells. In our laboratory, its observed that loss of nonmuscle myosin IIA not only cause morphology changes, it can also affect isometric tension production in endothelial cell. Our force measurement data showed that loss of myosin IIA can induce decrease in both baseline force and agonist-stimulated isometric tension produced in endothelial cells compared to control cells ( Fig. 3.17 ). And the parallel western blot result also indicated that myosin IIA level was significantly decreased in ad-shRNAi-IIA infected cells while myosin IIB level was not affected by myosin IIA knockdown. These results suggested that the baseline force and agonist-stimulated isometric tension produced in myosin IIA knockdown cells may result primarily from nonmuscle myosin IIB. In the absence of myosin IIA, myosin IIB can still produce considerable baseline force and agonist-stimulated isometric tension force. We concluded that both myosin IIA and IIB contribute to the cell contractility of endothelial cell in normal condition. Loss of myosin IIA will result the decrease in the total baseline force produced as well as agonist-stimulated isometric tension force produced. In the absence of myosin IIA, can myosin IIB maintain contractile force to the same degree as in control cells or increase force production to partially compensate for the loss of the myosin IIA needs to be determined.
In our laboratory, we are also interested in the effect of loss of myosin IIB on endothelial cells. More surprising was our finding that in myosin IIB knockdown cells, actin filaments within the cytoplasm were not disrupted or lost like what we observed in myosin IIA knockdown cells previously stated. Myosin IIB deficient cells displayed regular cell shape and cytoskeleton, and actin filaments were bound into stress fibers running through cytoplasm. In addition, cells maintained their regular shapes, no exaggerated membrane protrusion occured. Taken together, loss of nonmuscle myosin IIA in endothelial cells leads to disruption of stress fibers resulting in apparent changes in cell shape and membrane protrusions. Meanwhile, different from those phenotypes in myosin IIA knockdown cells, in endothelial cells with ablation of nonmuscle myosin IIB while exclusively express nonmuscle myosin IIA isoform, cells displayed normal cell shape and actin filament. One hypothesis is that the stabilization of stress fiber as well as maintenance of cell shape depends heavily on nonmuscle myosin IIA, which is responsible for interacting with actin filaments and other cross-link proteins to form high order stress fibers in cells. In myosin IIA knockdown cells ( Fig. 3.8 ), myosin IIB colocalized with short and disorganized stress fibers, suggesting that nonmuscle myosin IIB also contributes to stress fiber development, but might not be sufficient in maintenance the high order structure when nonmuscle myosin IIA is ablated from cells.
In summary, our data have shown that knocking down the expression of nonmuscle myosin IIA in mouse endothelial cells causes a dramatic decrease of stress fiber as well as alteration of actin cytoskeleton organization with concomitant changes in cell shape, migration and contractile force. Our data consistant with previous work by other investigators provided strong evidence supporting the idea that nonmuscle myosin IIA plays an important part in regulating cell shape, motility and contraction. More work is required for a further understanding of how these activities are monitored by the cell and the role myosin IIA interfere in endothelial cell monolayer permeability by regulating cytoskeleton.
